4-786567-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006651.4(CPLX1):āc.339C>Gā(p.Asp113Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,609,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_006651.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPLX1 | NM_006651.4 | c.339C>G | p.Asp113Glu | missense_variant | 4/4 | ENST00000304062.11 | |
CPLX1 | XM_011513391.2 | c.294C>G | p.Asp98Glu | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPLX1 | ENST00000304062.11 | c.339C>G | p.Asp113Glu | missense_variant | 4/4 | 1 | NM_006651.4 | P1 | |
CPLX1 | ENST00000505203.1 | c.276C>G | p.Asp92Glu | missense_variant | 5/5 | 2 | |||
CPLX1 | ENST00000504062.1 | c.294C>G | p.Asp98Glu | missense_variant | 3/3 | 3 | |||
CPLX1 | ENST00000506404.1 | n.392C>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152028Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 241962Hom.: 0 AF XY: 0.00000761 AC XY: 1AN XY: 131478
GnomAD4 exome AF: 0.00000823 AC: 12AN: 1457822Hom.: 0 Cov.: 36 AF XY: 0.00000552 AC XY: 4AN XY: 724952
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74386
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 11, 2022 | This variant has not been reported in the literature in individuals affected with CPLX1-related conditions. This variant is present in population databases (rs202217824, gnomAD 0.01%). This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 113 of the CPLX1 protein (p.Asp113Glu). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at